11 May 2015 : Original article
Efficacy and Safety of Low Accelerating Dose Regimen of Interferon/Ribavirin Antiviral Therapy in Patients with Hepatitis C Virus Recurrence after Liver Transplantation
Haibin SuA, Zhenwen LiuB, Yanlin SunD, Hanwei LiE, Shuangnan ZhouF, Xia ZhouB, Yinjie GaoD, Rujia TangE, Dali ZhangD, Min ZhangFDOI: 10.12659/AOT.892255
Ann Transplant 2015; 20:263-268
Abstract
BACKGROUND: Achievement of sustained virological response (SVR) is the main goal of interferon/ribavirin (IFN/RBV) antiviral therapy in patients with hepatitis C virus (HCV) recurrence after orthotopic liver transplantation (OLT). In this study, we have retrospectively evaluated the efficacy and safety of low accelerating dose regimen (LADR) of IFN/RBV in patients with HCV recurrence after OLT.
MATERIAL AND METHODS: Thirty-one patients with HCV recurrent after OLT who were treated with LADR of antiviral therapy were analyzed in our study. Data of virological response (including rapid, early, end of treatment and sustained virological responses, designated as RVR, EVR, ETVR, and SVR, respectively) and liver histological change were collected.
RESULTS: All patients received tacrolimus (TAC) and/or mycophenolate mofetil (MMF) for immunosuppression. Seven patients (23%), 6 patients (19%), and 18 patients (58%) finished complete treatment (CT), complete duration (CD), and incomplete treatment (IT), respectively. Twenty-four patients (77%) achieved ETVR. Among them, 8 patients (33%) achieved SVR, while 16 (67%) patients relapsed within 24 weeks after the end of the treatment. Univariate analysis showed that pretreatment viral load (p=0.002) as well as treatment dose and duration (p<0.001) were positively associated with SVR. Flu-like side effects were observed in all patients and 17 (54.8%) discontinued treatment due to adverse events.
CONCLUSIONS: SVR achievement and tolerability to LADR of IFN/RBV therapy in our study are moderate in patients with HCV recurrence after liver transplantation. Pretreatment viral load and treatment dose and duration are positively related to SVR.
Keywords: Abortion, Therapeutic, liver abscess, Liver Abscess, Amebic
In Press
18 Mar 2024 : Original article
Does Antibiotic Use Increase the Risk of Post-Transplantation Diabetes Mellitus? A Retrospective Study of R...Ann Transplant In Press; DOI: 10.12659/AOT.943282
20 Mar 2024 : Original article
Transplant Nephrectomy: A Comparative Study of Timing and Techniques in a Single InstitutionAnn Transplant In Press; DOI: 10.12659/AOT.942252
28 Mar 2024 : Original article
Association Between FEV₁ Decline Rate and Mortality in Long-Term Follow-Up of a 21-Patient Pilot Clinical T...Ann Transplant In Press; DOI: 10.12659/AOT.942823
02 Apr 2024 : Original article
Liver Transplantation from Brain-Dead Donors with Hepatitis B or C in South Korea: A 2014-2020 Korean Organ...Ann Transplant In Press; DOI: 10.12659/AOT.943588
Most Viewed Current Articles
05 Apr 2022 : Original article
Impact of Statins on Hepatocellular Carcinoma Recurrence After Living-Donor Liver TransplantationDOI :10.12659/AOT.935604
Ann Transplant 2022; 27:e935604
12 Jan 2022 : Original article
Risk Factors for Developing BK Virus-Associated Nephropathy: A Single-Center Retrospective Cohort Study of ...DOI :10.12659/AOT.934738
Ann Transplant 2022; 27:e934738
22 Nov 2022 : Original article
Long-Term Effects of Everolimus-Facilitated Tacrolimus Reduction in Living-Donor Liver Transplant Recipient...DOI :10.12659/AOT.937988
Ann Transplant 2022; 27:e937988
15 Mar 2022 : Case report
Combined Liver, Pancreas-Duodenum, and Kidney Transplantation for Patients with Hepatitis B Cirrhosis, Urem...DOI :10.12659/AOT.935860
Ann Transplant 2022; 27:e935860